Table 1

Ligand binding properties of β2ARG and β2ARCAMG expressed in Sf9 membranes: effect of GTPγS

LigandKhKlRhKhGTPγSKlGTPγSRhGTPγS
nM % nM %
β2ARG
 (−)-ISO1.0  ± 0.6100  ± 3844.3  ± 3.8190  ± 20
 (+)-ISO17  ± 43400  ± 31038.9  ± 4.44300  ± 500
 SAL21  ± 52000  ± 45037.7  ± 4.42900  ± 650
 DOB62  ± 232300  ± 60045.0  ± 5.12800  ± 660
 EPH3000  ± 110015000  ± 2000
 DCI96  ± 17140  ± 20
 ICI1.7  ± 0.31.9  ± 0.4
β2ARCAMG
 (−)-ISO0.2  ± 0.13.8  ± 1.335.4  ± 4.02.0  ± 1.013  ± 2.265.5  ± 8.9
 (+)-ISO3.8  ± 1.075  ± 1356.1  ± 5.3135  ± 21
 SAL2.2  ± 1.176  ± 1643.6  ± 5.11.9  ± 0.9160  ± 2016.3  ± 3.3
 DOB16  ± 41400  ± 43080.0  ± 6.8500  ± 170
 EPH32  ± 121800  ± 40056.0  ± 8.92900  ± 600
 DCI12  ± 4240  ± 8048.8  ± 4.9470  ± 120
 ICI3.4  ± 0.41.4  ± 0.4

[3H]DHA binding was determined as described underExperimental Procedures in Sf9 membranes expressing β2ARG (3.3–7.5 pmol/mg) or β2ARCAMG (2.5–4.9 pmol/mg). The ligand competition binding curves shown in Figs. 2, 5, and 7 were analyzed by nonlinear regression for best fit to single-site or two-site binding.Kh and Kl designate the dissociation constants for high- and low-affinity agonist binding, respectively. %Rh indicates the percentage of receptors displaying high agonist affinity. The corresponding values obtained in the presence of GTPγS (10 μM) are designatedKhGTPγS, KlGTPγS, and %RhGTPγS, respectively. Dissociation constants for ICI are listed below Kl andKlGTPγS, respectively. Data shown represent the means ± S.D. of four to seven independent experiments performed in triplicate.